Relationship between blood fibrinogen concentration and pathological features of cancer patients: A 139-case clinical study

OnLine Journal of Biological Sciences

Volumn 7, Issue 1, 2007, Pages 8-11

  Lu, Da Yong ^a   Chen, Xue Liang ^b   Huang, Min ^c   Xu, Bin ^c   Ding, Jian ^c  

^a SHANGHAI UNIVERSITY   (China)

^b Shanghai Jing An District Hospital   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Cancer chemotherapy; Cancer pathogenesis; Fibrinogen; Metastasis; Neoplasm

Indexed keywords

EID: 34347255302     PISSN: None     EISSN: 16084217     Source Type: Journal    
DOI: 10.3844/ojbsci.2007.8.11     Document Type: Article

References (16)

1. Zacharski, L.R., 1981. Anticoagulation in the treatment of cancer in man. In: Donati MB, Davidson J.E., Garattini E, Ed.: Malignancy and hemostatic system. NY. Raven Press: pp: 113-128.
2. Staton, C.A., N.J. Brown and C.E. Lewis. 2003. The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opinion Biol. Therapy, 3: 1105-1120.
3. Kyrle, P.A., S. Eichinger, 2005. Deep vein thrombosis, Lancet, 365: 1163-1174.
4. Lam, T.H., L.J. Liu, E.D. Janus, C. Bourke and A.J. Hedley, 1999. The relationship between fibrinogen and other coronary heart disease risk factors in a Chinese population. Atherosclerosis, 143: 405-413.
5. Iyigun, I. and Y. Bakirci, 2002. Plasma concentrations of C-reactive protein and fibrinogen in ischaemic stroke. J. Int. Med. Res., 30: 591-596.
6. Bahia, L., L.G. Aguiar, N. Villela, D. Bottino, A.F. Godoy-Matos, B. Geloneze, M. Tambascia and E. Bouskela, 2006. Relationship between adipokines, inflammation, and vascular reactivity in lean controls and obese subjects with metabolic syndrome. Clinics, 61: 433-440.
7. Costantini, V. and L.R. Zacharski, 1992. The role of fibrin in tumor metastasis. Cancer Metastasis Rev. 11: 283-290.
8. Eikelboom, J.W. and S.R. Mehta, 2000. Venous thromboembolism and cancer. New Engl. J. Med. 343: 1337-1338.
9. Lu, D.Y., X.L. Chen and J. Ding, 2007. Treatment of solid tumors and metastases by fibrinogen-targeted anticancer drug therapy. Med. Hypotheses, 68:188-193.
10. Lu, D.Y., J.Y. Cao, Y.P. Huang, L. Gong,X.L. Chen, E.H. Chen and B. Xu, 1999. Comparison of some antineoplastic drugs on inhibiting thrombin catalyzing fibrinogen clotting in vitro. Chin. Med. J. 112: 1052-1053.
11. 125I-fibrinogen to two leukemia cell lines in vitro. Int. J. Med. Res., 32: 488-491.
12. Palumbo, J.S., J.M. Potter, L.S. Kaplan, K. Talmage, D.G. Jackson and J.L. Degen, 2002. Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res., 62: 6966-6972.
13. Rybarczyk B.J. and P.J. Simpson-Haidaris, 2000. Fibrinogen assembly, secretion, and deposition into extracellular matrix by MCF-7 human breast carcinoma cells. Cancer Res. 60: 2033-2039.
14. Browder, T., J. Folkman and S. Pirie-Shepherd, 2000. The hemostatic system as a regulator of angiogenesis. JBC. 275: 1521-1524.
15. Dvorak, H.F., 2003. How tumors make bad blood vessels and stroma. Am. J. Path. 162: 1747-1757.
16. Lu, D.Y., X.L. Chen and J.Ding, 2006. Individualized cancer chemotherapy, integrating drug sensitivity tests, pathological profile analysis and computational coordination - an effective strategy to improve clinical treatment. Med Hypotheses., 66: 45-51.